乳房肉腫の化学療法および標的療法の最近の進歩
Ana Dolcan1, Daniela A Ferraro1, Giovani Dei Tos1
1Medical Oncology, Lausanne University Hospital Switzerland, Lausanne, Switzerland.
Expert review of anticancer therapy
|December 24, 2025
まとめ
乳房肉腫(BS)はまれであるが攻撃的な癌である。このレビューでは、局所および転移性乳房肉腫の現在の治療基準への新規治療法とその統合を探る。
科学分野:
- 腫瘍学
- 肉腫研究
背景:
- 乳房肉腫(BS)は、罹患率と死亡率が高い、まれで攻撃的な悪性腫瘍である。
- 標的療法の進歩にもかかわらず、現在の治療は主に細胞毒性化学療法に依存している。
研究 の 目的:
- 乳房肉腫療法の最近の進歩をレビューする。
- 新規治療法を標準治療に統合することを検討する。
- 特定のサブタイプに対する補助療法および標的療法の新たな傾向を強調する。
主な方法:
- 2025年1月までのPubMedの体系的な文献検索。
- インパクトの高い臨床試験、ガイドライン、および最近のレビューに焦点を当てる。
主要な成果:
- 乳房肉腫は、サブタイプ間で有意な異種性を示す。
- 局所および転移性疾患の両方に対して、新規治療戦略が出現している。
- ゲノムの洞察はますます認識されているが、まだ個別化治療に完全に統合されていない。
結論:
- 新規治療法の統合には、BSサブタイプの異種性を理解する必要がある。
- 将来の研究では、ゲノムの洞察と強化された臨床試験デザインを優先する必要がある。
- 結果を改善するには、学際的な協力と実世界のデータが不可欠である。
関連する概念動画
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K


